248 related articles for article (PubMed ID: 30709366)
1. A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma.
Vogin G; Wambersie A; Koto M; Ohno T; Uhl M; Fossati P; Balosso J;
Radiat Oncol; 2019 Feb; 14(1):24. PubMed ID: 30709366
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.
Sprave T; Verma V; Sterzing F; Bruckner T; Hees K; Land B; Jäkel O; Herfarth K; Debus J; Uhl M
Anticancer Res; 2018 Aug; 38(8):4853-4858. PubMed ID: 30061259
[TBL] [Abstract][Full Text] [Related]
3. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
Iannalfi A; D'Ippolito E; Riva G; Molinelli S; Gandini S; Viselner G; Fiore MR; Vischioni B; Vitolo V; Bonora M; Ronchi S; Petrucci R; Barcellini A; Mirandola A; Russo S; Vai A; Mastella E; Magro G; Maestri D; Ciocca M; Preda L; Valvo F; Orecchia R
Neuro Oncol; 2020 Sep; 22(9):1348-1358. PubMed ID: 32193546
[TBL] [Abstract][Full Text] [Related]
4. Concepts and terms for dose/volume parameters in carbon-ion radiotherapy: Conclusions of the ULICE taskforce.
Vogin G; Wambersie A; Pötter R; Beuve M; Combs SE; Magrin G; Mayer R; Mock U; Sarrut D; Schreiner T; Fossati P; Balosso J
Cancer Radiother; 2018 Dec; 22(8):802-809. PubMed ID: 30327228
[TBL] [Abstract][Full Text] [Related]
5. RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV.
Gillmann C; Jäkel O; Karger CP
Radiother Oncol; 2019 Dec; 141():234-238. PubMed ID: 31522880
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric effects of residual uncertainties in carbon ion treatment of head chordoma.
Fattori G; Riboldi M; Scifoni E; Krämer M; Pella A; Durante M; Ronchi S; Bonora M; Orecchia R; Baroni G
Radiother Oncol; 2014 Oct; 113(1):66-71. PubMed ID: 25156944
[TBL] [Abstract][Full Text] [Related]
7. Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma.
Lorenzo C; Andrea P; Barbara V; Denis P; Rosaria FM; Piero F; Viviana V; Alberto I; Mario C; Brugnatelli S; Tommaso D; Bugada D; Marcello M; Mario A; Francesca V; Roberto O; Paolo D
World J Surg Oncol; 2016 Aug; 14(1):211. PubMed ID: 27507254
[TBL] [Abstract][Full Text] [Related]
8. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients.
Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Scholz M; Kraft G; Wannenmacher M; Debus J
Strahlenther Onkol; 2003 Sep; 179(9):598-605. PubMed ID: 14628125
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy: Organ doses in pediatric brain tumor treatment.
Matsumoto S; Yonai S; Bolch WE
Med Phys; 2019 Dec; 46(12):5824-5832. PubMed ID: 31603561
[TBL] [Abstract][Full Text] [Related]
10. Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes.
Lu VM; O'Connor KP; Mahajan A; Carlson ML; Van Gompel JJ
J Neurooncol; 2020 May; 147(3):503-513. PubMed ID: 32206977
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of skull base chordoma treated with high-dose carbon-ion radiotherapy.
Koto M; Ikawa H; Kaneko T; Hagiwara Y; Hayashi K; Tsuji H
Head Neck; 2020 Sep; 42(9):2607-2613. PubMed ID: 32472716
[TBL] [Abstract][Full Text] [Related]
12. Future Perspective: Carbon Ion Radiotherapy for Head and Neck and Skull Base Malignancies.
Rutenberg MS; Beltran C
Oral Maxillofac Surg Clin North Am; 2023 Aug; 35(3):485-492. PubMed ID: 37117091
[TBL] [Abstract][Full Text] [Related]
13. Assessment of volume segmentation in radiotherapy of adolescents; a treatment planning study by the Swedish Workgroup for Paediatric Radiotherapy.
Kristensen I; Agrup M; Bergström P; Engellau J; Haugen H; Martinsson U; Nilsson K; Taheri-Kadkhoda Z; Lindh J; Nilsson P
Acta Oncol; 2014 Jan; 53(1):126-33. PubMed ID: 23577745
[TBL] [Abstract][Full Text] [Related]
14. MRI-based tumour control probability in skull-base chordomas treated with carbon-ion therapy.
Buizza G; Molinelli S; D'Ippolito E; Fontana G; Pella A; Valvo F; Preda L; Orecchia R; Baroni G; Paganelli C
Radiother Oncol; 2019 Aug; 137():32-37. PubMed ID: 31051372
[TBL] [Abstract][Full Text] [Related]
15. [Carbon ion irradiation of skull base tumors at GSI. First clinical results and future perspectives].
Debus J; Haberer T; Schulz-Ertner D; Jäkel O; Wenz F; Enghardt W; Schlegel W; Kraft G; Wannenmacher M
Strahlenther Onkol; 2000 May; 176(5):211-6. PubMed ID: 10847117
[TBL] [Abstract][Full Text] [Related]
16. Treatment planning for carbon ion radiotherapy in Germany: review of clinical trials and treatment planning studies.
Jäkel O; Krämer M; Schulz-Ertner D; Heeg P; Karger CP; Didinger B; Nikoghosyan A; Debus J
Radiother Oncol; 2004 Dec; 73 Suppl 2():S86-91. PubMed ID: 15971317
[TBL] [Abstract][Full Text] [Related]
17. Treatment planning for heavy ion radiotherapy: clinical implementation and application.
Jäkel O; Krämer M; Karger CP; Debus J
Phys Med Biol; 2001 Apr; 46(4):1101-16. PubMed ID: 11324954
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcoma in Older Patients.
Kinoshita H; Yonemoto T; Yamada S; Imai R
Anticancer Res; 2024 Apr; 44(4):1773-1780. PubMed ID: 38537982
[TBL] [Abstract][Full Text] [Related]
19. An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia.
Ahern V; Adeberg S; Fossati P; Garrett R; Hoppe B; Mahajan A; Orlandi E; Orecchia R; Prokopovich D; Seuntjens J; Thwaites D; Trifiletti D; Tsang R; Tsuji H
Radiother Oncol; 2023 Oct; 187():109816. PubMed ID: 37480996
[TBL] [Abstract][Full Text] [Related]
20. How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy.
Molinelli S; Magro G; Mairani A; Allajbej A; Mirandola A; Chalaszczyk A; Imparato S; Ciocca M; Fiore MR; Orlandi E
Radiother Oncol; 2021 Oct; 163():209-214. PubMed ID: 34506829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
